EVA Pharma to Start Manufacturing Antiviral Drug Favipiravir
Eva Pharma, one of the major international pharmaceutical companies operating in Cairo,
has announced it that it will start manufacturing a new drug based on the active ingredient “Favipiravir” an anti-viral compound that has proven to be effective in combating the new coronavirus in Russia and in treating patients in several areas.
The potent cure is currently being tested in several other states outside Russia including Japan.
Dr. Riyad Armanius,
Managing Director of Eva Pharma , said
that his company has already started manufacturing the drug within it’s factories, and has already started producing samples,
explaining that there is coordination between Eva and the medical authorities in Egypt to approve that the drug is safe to use in the treatment of patients with the emerging coronavirus during the upcoming period.
Earlier this month, Eva Pharma
announced it had reached a “historic” deal with Gilead Sciences Inc to become the licensed manufacturer of the US company’s antiviral treatment Remdesivir for coronavirus in 127 countries.
Sada El balad
https://see.news/eva-pharma-to-start-manufacturing-antiviral-drug-favipiravir/